Gold Coast Hospital

Southport 4215

1 studies enrolling now · 6 studies all time

What they study most

Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), B-cell Non Hodgkin Lymphoma, DLBCL, FL, Granulomatosis With Polyangiitis (Wegener's) (GPA), High-grade B-cell Lymphoma (HGBCL), Indolent B-cell Non-Hodgkin Lymphoma (iNHL), MCL, Marginal Zone Lymphoma (MZL), Melanoma Stage III, Melanoma Stage IV, Microscopic Polyangiitis (MPA)

Studies at this site

• A Study of ARC-02 in B-cell NHL — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed